Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Revista
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Lupus ; 23(10): 1069-72, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24786784

RESUMEN

Rheumatologists are increasingly aware of the entity synovitis with pitting edema. The remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome has been reported with an array of conditions that include polymyalgia rheumatica, rheumatoid arthritis, Sjögren's syndrome and psoriatic arthropathy. Synovitis with pitting edema is now being increasingly recognized with systemic lupus erythematosus (SLE). We report a patient who presented with edema of hands and feet and was diagnosed eventually with definite SLE. With magnetic resonance imaging, joint effusions and tenosynovitis were confirmed to be associated with the otherwise-unexplained extremity edema.


Asunto(s)
Edema/etiología , Lupus Eritematoso Sistémico/complicaciones , Sinovitis/etiología , Niño , Edema/diagnóstico , Edema/tratamiento farmacológico , Femenino , Pie , Mano , Humanos , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/tratamiento farmacológico , Imagen por Resonancia Magnética , Esteroides/uso terapéutico , Sinovitis/diagnóstico , Sinovitis/tratamiento farmacológico , Resultado del Tratamiento
2.
Lupus ; 20(14): 1551-3, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21828160

RESUMEN

Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Cases complicated with DAH often have active SLE with multi-organ involvement, especially lupus nephritis. We describe a rare case of DAH as the first presenting manifestation of SLE in the absence of lupus nephritis. Remission was induced by IV methylprednisolone, IV cyclophosphamide, and plasmapheresis. Further cycles of cyclophosphamide were prevented by recurrent infections. Maintenance of remission was successfully achieved with oral mycophenolate mofetil 1 g twice daily, with a good control of SLE and without further DAH episodes.


Asunto(s)
Hemoptisis/etiología , Inmunosupresores/uso terapéutico , Lupus Eritematoso Sistémico/complicaciones , Ácido Micofenólico/análogos & derivados , Femenino , Hemoptisis/tratamiento farmacológico , Humanos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Ácido Micofenólico/uso terapéutico , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA